How much is Moderna worth in 2026?

Moderna has a current valuation of N/A based on their Later Stage VC (Series G) round and secondary market data.

How much funding has Moderna raised?

Moderna has raised N/A in total funding across 1 funding rounds.

Moderna

Drug Discovery

Moderna valuation and funding history | Last updated: February 1, 2018 | 1 funding rounds

Current Valuation

N/A

As of February 1, 2018

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series G)

$500.0M

Last Funding

Feb 2018

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 1, 2018	Later Stage VC (Series G)	$500.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Moderna is currently valued at N/A as of February 1, 2018.

Track Moderna Valuation Updates

Get notified when Moderna raises new funding or valuation changes

Explore More Data

Detailed analysis for Moderna

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Moderna's valuation history, funding rounds, and growth metrics.

No credit card required

What is Moderna Worth in 2026?

Moderna is a leading private company in the Drug Discovery sector. Track Moderna's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Moderna Valuation is Determined

Private company valuations like Moderna's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.